drugset / Trial / NCT03306732

Thiamine Supplementation in High Risk Cardiac Surgery Patients

NCT03306732

RandomizedParallel-groupTriple-blindTreatment

Summary

This pilot trial will evaluate the ability of thiamine to affect on postoperative vasoplegia in high risk cardiac surgery patients

Timeline

Start
2017-10-19
Primary completion
2018-05-18
Completion
2018-06-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Thiamine Other / unclassified 200 mg

Indications

No indication recorded.